44 results about "Ophthalmia" patented technology

The invention provides an ophthalmic, otic or nasal pharmaceutical composition, comprising levofloxacin or the pharmaceutical acceptable salts thereof and loteprednol etabonate, wherein the weight ratio of loteprednol etabonate to levofloxacin is 1:0.2-5. The use of ophthalmic, otic or nasal pharmaceutical composition of the invention in preparation of the medication for treatment of conjunctivitis, keratitis, blepharitis, dacrycystitis, hordeolum, corneal ulcer and ocular infection accompanied with ophthalmitis and even inflammation of the surrounding tissues, to prevent increase of bacterial infection risks and the tissue inflammation of the infected area after the ophthalmic surgeries or ocular injuries, to treat or alleviate the bacterial infection in combination with the tissue inflammation of the infected area, or to treat tympanitis, otitis externa and infective rhinitis.

The present invention relates to an eye drops for preventing and curing electric ophthalmitis with high cure rate and obvious therapeutic effect. Its composition contains dicaine hydrochloride 0.5g, sodium chloride 0.82g, 0.1% adrenaline injection solution 5 ml and distilled water adding to 100ml.

The invention belongs to the field of medical products, and discloses a medicine preparation for treating electric ophthalmia. The medicine preparation is prepared from the following raw materials: Chinese fevervine herb, weeping forsythia capsule, prepared rhizome of rehmannia, bamboo shavings, dwarf lilyturf tuber, belveder fruit, feather cockscomb seed, wild chrysanthemum flower, zedoary rhizome, buerger pipewort flower, common cnidium fruit, medicinal cyathula root, white paeony root, kudzuvine root, silktree albizzia bark, Chinese yam, codonopsis pilosula, oriental waterplantain rhizome, sea-ear shell and coptis chinensis. The medicine preparation disclosed by the invention is short in treatment cycle, quick in action and low in toxic or side effects, and cannot cause damages to the eyes.

The invention relates to a gel for lysozyme eye and a preparation method thereof. The gel for the lysozyme eye is applicable of treating various normal eye infection diseases, such as a pinkeye, an ophthalmia, a ceratitis, a keratohelcosis, a conjunctivitis and the like, which is caused by bacteria, Chlamydia, virus and drug-resistance bacteria. The gel for the lysozyme eye disclosed by the invention uses a solution containing 0.1-10.0% of lysozyme, 0.01-20% of water soluble macromolecule matrix, 0.1-10% of a pH modifier, 0.01-10% of a bacteriostat and 0.1-10% of a viscosity modifier and takes a solution with a pH value of 5.0-6.5 as a buffer solution. With the adoption of the receipt of the gel for the lysozyme eye provided by the invention, the time that drug lysozyme remains on an eye can be prolonged, and the bacteriostat efficiency of the lysozyme on the eye can be improved.

The invention relates to the novel use of human lysozyme, in particular the use of human lysozyme in pharmaceutical industry, specifically the use of human lisozima in preparing ophthalmocace treating medicine, such as epidemic conjunctivitis, opthalmitis, ceratitis, corneal ulcer diseases caused by bacterium, Chlamydia, viruses and drug resistant medicines. The gene recombination lysozyme has rich source, the eye drops prepared thereby are easy to use.

The invention discloses peppermint and liquorice root tea. The peppermint and liquorice root tea comprises the following components in parts by weight: 2-4 parts of peppermint leaves, 4-8 parts of liquorice root, 8-12 parts of heterophylly falsestarwort root and 100 parts of green tea. The peppermint and liquorice root tea disclosed by the invention has the effects of relieving heat and sunstroke, cooling, detoxifying, inducing sweat and dispelling exogenous evils, and also has a good curative effect against the symptoms of headache, ophthalmia, sore throat, wind-heat type common cold and the like. Particularly, after a pure natural botanical preservative is added, the shelf life of the tea is prolonged.

On the research basis that microbes of specific species are present in eyes of patients with different eye diseases, the invention discloses a method for establishing a model, and the method comprisesthe step of infecting a model carrier with the microbes. The model prepared by the method can be used for screening drugs for the eye diseases, and the eye diseases include senile macular degeneration, the behcet disease, the Vogt-Koyanagi-Harada syndrome, uveitis, retinopathy, xerophthalmia, sympathetic ophthalmia, trachoma, cataract, conjunctivitis, chalazion, glaucoma, muscae volitantes and the like.

A traditional Chinese medicine formula for treating electric ophthalmia is characterized by comprising the following technological process: components comprise 35 g of Laoshan green tea, 25 g of paederia scandens, 20 mL of fresh milk, 15 g of borax, 10 g of rhizoma coptidis, 10 g of oriental waterplantain rhizome, 10 g of cnidium monnieri, 10 g of radix cyathulae, and 3 g of Sichuan pepper; and a method comprises the steps: grinding the above materials except the fresh milk into a fine powder according to the proportion, blending with the fresh milk evenly, wrapping with gauze, and applying on an eye for 5 times a day and for 20 minutes each time. The problems that a conventional traditional Chinese medicine formula for treating electric ophthalmia is long in healing time and non-significant in curative effect, cannot heal eye pain symptoms, cannot repair damaged cell tissues, even makes electric ophthalmia repeatedly attacked and has a blindness risk are solved, and the traditional Chinese medicine formula is suitable for treating electric ophthalmia.

The present application discloses a compound, or enantiomers, stereoisomers, rotamers, tautomers, racemates or prodrug of said compound, or pharmaceutically acceptable salts, solvates or esters of said compound, or of said prodrug, said compound having the general structure shown in Formula 1 or a pharmaceutically acceptable salt, solvate or ester thereof. Also disclosed is a method of treating chemokine mediated diseases, such as, palliative therapy, curative therapy, prophylactic therapy of certain diseases and conditions such as inflammatory diseases (non-limiting example(s) include, psoriasis), autoimmune diseases (non-limiting example(s) include, rheumatoid arthritis, multiple sclerosis), graft rejection (non-limiting example(s) include, allograft rejection, zenograft rejection), infectious diseases (e.g , tuberculoid leprosy), fixed drug eruptions, cutaneous delayed-type hypersensitivity responses, ophthalmic inflammation, type I diabetes, viral meningitis and tumors using a compound of Formula 1.

The invention discloses new application for pien tze huang in the aspect of protecting a memory function and resisting cerebral ischemia. The pien tze huang belongs to a traditional first-grade state-protection traditional Chinese medicine, is processed and prepared into various types of conventional formulations applied clinically, has effects of inflammation diminishing, cooling, detoxication, detumescence, pain relieving and the like, has good curative effects for diseases of pain, fever and the like caused by oxyhepatitis, ophthalmia, otitis and all inflammations, and further has an obvious inhibiting effect for cancer cells of the digestive system of a patient. The pien tze huang in the invention has a remarkable effect in the aspect of protecting the memory function and resisting cerebral ischemia. In addition, preventive therapy by the aid of the pien tze huang can relieve apoplexy severity and prolong survival life of patients with apoplexy, and simultaneously, the effect of the pien tze huang is confirmed. Mechanism research of the new application for the pien tze huang is realized, and accordingly, the new application for the pien tze huang has a more scientific basis.

The present invention is one kind of Chinese medicine composition for treating electric ophthalmia and belongs to the field of Chinese medicine technology. The Chinese medicine is prepared with prepared rhizome of rehmannia, Chinese fevervine and borneol as main material, and the preferred composition is prepared rhizome of rehmannia 45-55 weight portions, Chinese fevervine 35-45 weight portions and borneol 5-15 weight portions. The Chinese medicine composition can reduce eye's pain fast and conjunctiva hyperemia fast, nourish and repair damaged eye tissue and restore eyesight.

The invention belongs to the technical field of medicine and discloses a preparing method for a composition used for treating electric ophthalmia. According to the method, Chinese herbal medicine raw materials such as concha haliotidis, rhizoma coptidis, codonopsis pilosula, Chinese yam, rhizome alismatis, fructus cnidii, medicinal cyathula roots, radix paeoniae alba, radix puerariae, buerger pipewort flowers, semen celosiae, wild chrysanthemums, curcuma zedoaria, fructus forsythiae, lycium barbarum, coronene, dried tangerine or orange peel, caulis bambusae, radix ophiopogonis and belvedere fruit. The method is simple and feasible, the material cost is low, the prepared composition is short in treatment cycle and takes effects fast, and the toxic and side effect is small.

The invention relates to a compound traditional Chinese veterinary medicine premix for preventing and treating avian influenza. The compound traditional Chinese veterinary medicine premix comprises the following components in parts by weight: 40-60 parts of pine needle leaves, 20-40 parts of wild chrysanthemum flowers, 10-30 parts of rhizoma atractylodis, 5-10 parts of concha ostreae, 10-20 parts of folium artemisiae argyi, 5-10 parts of dandelion, 1-5 parts of polygonum multiflorum and 15-54 parts of an auxiliary material. The compound traditional Chinese veterinary medicine premix has good control effect on chicken bronchitis, laryngotracheitis, rhinitis, ophthalmia and the like caused by the avian influenza, has the functions of improving the eyesight, dispelling wind heat, detoxifying and the like, has a certain function on preventing the avian influenza and the like, and promotes the growth and the development of poultry. The compound traditional Chinese veterinary medicine premix is non-toxic, harmless and free from drug residues, is prepared by using conventional equipment, and is simple in technology, low in cost and convenient in industrialization.

A method of treating non-infectious, inflammatory blepharitis includes administering to the affected eye of a subject an effective amount of an active ingredient in an ophthalmically acceptable vehicle for a sufficient period of time to treat the non-infectious, inflammatory blepharitis. The active ingredient consists essentially of a glucocorticoid in an ophthalmically acceptable vehicle that includes an aqueous polymer suspension that when mixed with tear fluid provides a sustained release of said active ingredient. The aqueous polymer suspension includes a carboxyl-containing polymer having less than about 5% by weight cross-linking agent and has a viscosity in a range from about 1,000 to about 30,000 centipoises. A kit includes: (a) a composition comprising about 0.1% by weight dexamethasone in this ophthalmically acceptable vehicle and (b) instructions for using the composition of (a) for the treatment of blepharitis.

A method of treating blepharitis includes administering to the affected eye of a subject an effective amount of an active ingredient in an ophthalmically acceptable vehicle for a sufficient period of time to treat blepharitis. The active ingredient consists essentially of a glucocorticoid in an ophthalmically acceptable vehicle that includes an aqueous polymer suspension that when mixed with tear fluid provides a sustained release of said active ingredient. The aqueous polymer suspension includes a carboxyl-containing polymer having less than about 5% by weight cross-linking agent and has a viscosity in a range from about 1,000 to about 30,000 centipoises. A kit includes: (a) a composition comprising about 0.1% by weight dexamethasone in this ophthalmically acceptable vehicle and (b) instructions for using the composition of (a) for the treatment of blepharitis.

The invention aims at providing a diet therapy formula for electric ophthalmia. A product prepared by adopting the diet therapy formula comprises the following components by mass ratio: 10-20g of semen cassiae, 10-20g of feverfew flowers and 110-150g of polished round-grained rice. The diet therapy formula is simple, and the product is free of a side effect and low in cost.

The present invention discloses eye medicine preparation with effective component extracted from shellfish meat and its use. There is high content of taurine in retina as the important factor of photoreceptor, and lack of taurine will result in the degradation and the optical conductance suppression of the photoreceptor. Shellfish meat contains rich amino acid, especially taurine, and trace elements and zinc, so that effective component is extracted from shellfish meat and prepared into eye medicine preparation. The pharmacological experiments show that the medicine of the present invention can treat cataract, eliminating eye fatigue, correct eyesight, resist inflammation, and treat acute and chronic conjunctivitis, ceratitis and other eye diseases.

The invention belongs to the technical field of medicines and discloses a pharmaceutical preparation for treating electric ophthalmia. The pharmaceutical preparation for treating electric ophthalmia is prepared from the following raw materials: coptis chinensis, concha haliotidis, rhizoma alismatis, fructus cnidii, medicinal cyathula roots, radix paeoniae alba, roots of kudzu vines, pipewort, seeds of feather cockscomb, mother chrysanthemum, curcuma zedoary, fructus forsythia, wolfberries, amomun kravanh, selfheal, pericarpium citri reticulatae, liquorice, radix ophiopogonis, fructus kochiae and angelica sinensis. The pharmaceutical preparation provided by the invention is short in treatment cycle, quick to take effect and simple in preparation process.

The invention relates to a Chinese medicinal composition for treatment of edema and ophthalmia and a preparation method thereof. The Chinese medicinal composition is characterized by having the efficacy of clearing away heat and toxic materials, resisting inflammation, inducing diuresis and reducing edema, dispelling wind and removing obstruction in meridians, stopping bleeding, invigorating blood circulation and alleviating pain, etc., and can eliminate edema symptom proteinuria, hematuria, erythrocyte cylindruria, dropsy, high blood pressure, inflammation and the like. The matrix is prepared from the following Chinese medicinal composition and pharmaceutical excipients by weight: 1-50 parts of Scutellaria baicalensis, 1-100 parts of Stephania longa, 1-50 parts of acorus gramineus, and 1-50 parts of Pseudo-ginseng. The composition of the invention cares the whole of human body, prevents complications, treats both symptoms and root causes, has no toxic or side effect, and also has significant curative effect on some symptoms on which western medicines are non-effective. The composition provided by the invention is applied to clinical treatment of 12 edema cases, wherein the minimum age is 6 years old, the maximum age is 48 years old, the shortest disease course is 5 days, the longest disease course is 3 months, and all the cases are cured. The composition is applied to treatment of 26 ophthalmia cases, wherein the minimum age is 4 years old, the maximum age is 56 years old, the shortest disease course is 1 day, the longest disease course is 15 days, and all the cases are cured.

The invention discloses novel application of Pien Tze Huang and a preparation of Pien Tze Huang to the protection of a memory function and the resistance of cerebral ischemia. Pien Tze Huang, which is taken as the traditional national first-class Chinese medicine protection variety, is prepared into multiple kinds of conventional formulations which are clinically applied at present; Pien Tze Huang has the effects of reducing inflammation, cooling, releasing toxin, relieving swelling and pain and the like, and has a good effect of treating diseases such as pain and fever which are caused by acute hepatitis, ophthalmia and otitis as well as all inflammations; and in addition, Pien Tze Huang has a remarkable effect of inhibiting cancer cells of digestive systems. Pien Tze Huang has remarkable effects of protecting the memory function and resisting cerebral ischemia. The novel application of Pien Tze Huang is subjected to mechanism research, so that the novel application of Pien Tze Huang has a relatively scientific basis.

The invention belongs to the technical field of medicines and discloses a preparation process of a protection product used for treating electric ophthalmia of electric power staff. The protection product is prepared from the following raw materials: divaricate saposhnikovia root, peppermint, coptis root, Mongolian dandelion herb, sappan wood, dahurian patrinia herb, chrysanthemum, barbary wolfberry fruit, cicada slough, Chinese date, mulberry fruit, buerger pipewort flower, cape jasmine fruit, feather cockscomb seed, myrrh, glossy privet fruit, Indian buead, honeysuckle flower, mulberry leaf, Chinese dodder seed, Danshen root and liquorice root. The medicine preparation has short treatment cycle and takes effect quickly. The preparation process is simple.

The invention relates a medicine for treating electric ophthalmia, and belongs to the technical field of medical drugs. The invention aims at solving pathological problems and treatments problems of electric ophthalmia. The medicine for treating electric ophthalmia is characterized by being prepared from, by mass, 12 parts of ledebouriella seseloides wolff., 15 parts of isatis root, 15 parts of herba taxilli, 12 parts of cape jasmine, 15 parts of Balloon Flower, 12 parts of rehmannia glutinosa libosch, 10 parts of Chinadodder, 3 parts of pearl powder, 12 parts of cyperus rotundus, 10 parts of the root bark of the peony tree, 10 parts of dioscorea tokoro makino, 10 parts of heracleumhemsleyanum, 10 parts of forsythia suspense, 9 parts of radix ophiopogonis, and 9 parts of glycyrrhiza uralensis fisch.

The invention discloses a Chinese medicament for local use on ophthalmology prepared by using Huangtengsu as the main component, wherein the dosages types include eye ointment, eye gel and eye drop. The ophthalmology preparation not only has good effect in treating opthalmitis caused by bacteria and fungus, but also has appreciable protection action to chemical opthalmitis.

A method of treating non-infectious, inflammatory blepharitis includes administering to the affected eye of a subject an effective amount of an active ingredient in an ophthalmically acceptable vehicle for a sufficient period of time to treat the non-infectious, inflammatory blepharitis. The active ingredient consists essentially of a glucocorticoid in an ophthalmically acceptable vehicle that includes an aqueous polymer suspension that when mixed with tear fluid provides a sustained release of said active ingredient. The aqueous polymer suspension includes a carboxyl-containing polymer having less than about 5% by weight cross-linking agent and has a viscosity in a range from about 1,000 to about 30,000 centipoises. A kit includes: (a) a composition comprising about 0.1% by weight dexamethasone in this ophthalmically acceptable vehicle and (b) instructions for using the composition of (a) for the treatment of blepharitis.

The present invention discloses new application of neoarsphenamine. Said neoarsphenamine has the specific effect for curing the following 13 diseases: 1. rheumatoid arthritis; 2. various neuralgias of sciatica and intercostal neurolgia, etc. 3 angiitis; 4. leukemia; 5. psoriasis; 6 gonorrhea; 7 herpes zoster; 8. osteomyelitis and myelitis; 9 erysipelas; 10. nascsinusitis and frontal sinustits; 11. viral cold and viral ophthalmia; 12. eczema; and 13. carbuncle and cellulitis.

The invention discloses new application for pien tze huang in the aspect of protecting a memory function and resisting cerebral ischemia. The pien tze huang belongs to a traditional first-grade state-protection traditional Chinese medicine, is processed and prepared into various types of conventional formulations applied clinically, has effects of inflammation diminishing, cooling, detoxication, detumescence, pain relieving and the like, has good curative effects for diseases of pain, fever and the like caused by oxyhepatitis, ophthalmia, otitis and all inflammations, and further has an obvious inhibiting effect for cancer cells of the digestive system of a patient. The pien tze huang in the invention has a remarkable effect in the aspect of protecting the memory function and resisting cerebral ischemia. In addition, preventive therapy by the aid of the pien tze huang can relieve apoplexy severity and prolong survival life of patients with apoplexy, and simultaneously, the effect of the pien tze huang is confirmed. Mechanism research of the new application for the pien tze huang is realized, and accordingly, the new application for the pien tze huang has a more scientific basis.

The invention relates to a traditional Chinese medicine composition for treating acute ophthalmia, and belongs to the technical field of medical herb preparations and application thereof. According to the technical purposes, the traditional Chinese medicine composition for treating acute ophthalmia is easy to operate, fast in effect taking and free of side effects, and raw materials are easy to obtain. According to the technical scheme, the traditional Chinese medicine composition for treating acute ophthalmia comprises, by weight, 10-30 parts of concha haliotidis, 5-15 parts of radix bupleuri, 5-15 parts of mint, 3-10 parts of chrysanthemum, 3-15 parts of the root of common peony, 5-15 parts of the root bark of the peony tree, 5-15 parts of fried jasmine, 5-10 parts of fructus forsythiae, 5-12 parts of scutellaria baicalensis, 5-15 parts of radices sileris, 5-15 parts of tenuifolia and 5-10 parts of radix angelicae.

The invention relates to a Chinese medicine combination for treating Behcet disease, which is made from coptis chinensis, radix rehmanniae, prepared rhizome of rehmannia, gentian, scutellaria, baked licorice, cortex moutan, dentrobium, rhizoma anemarrhenae, pulp of cornus, codonopsis pilosula, atractylodes, honeysuckle stem, dandelion, gentian, dyers woad leaf and / or acceptable vectors in medicine. The invention also relates to the preparation method of the Chinese medicine combination. The Chinese medicine combination of the invention has the functions of removing damp-heat, nourishing liver and kidney, purging fire to eliminate toxin, etc. and is used for symptoms caused by the inflammation of fine vascular, such as oral and vulvar ulcers, ophthalmia, skin damages, etc.

The present invention discloses eye medicine preparation with effective component extracted from shellfish meat and its use. There is high content of taurine in retina as the important factor of photoreceptor, and lack of taurine will result in the degradation and the optical conductance suppression of the photoreceptor. Shellfish meat contains rich amino acid, especially taurine, and trace elements and zinc, so that effective component is extracted from shellfish meat and prepared into eye medicine preparation. The pharmacological experiments show that the medicine of the present invention can treat cataract, eliminating eye fatigue, correct eyesight, resist inflammation, and treat acute and chronic conjunctivitis, ceratitis and other eye diseases.